PolarisRx
Polaris Rx is an independent, privately held pharmacy services provider delivering clinical and correctional pharmacy programs to long-term care and post-acute facilities, justice agencies and specialty/infusion patients through 20+ company-operated pharmacies, and exclusive U.S. distribution of AstraZeneca's at-home FluMist vaccine.
- Company typePrivate
- Founded2015
- HeadquartersFort Lauderdale, United States
- Headcount501–1,000
- GTM typeB2B and B2C
- OfferingServices
What PolarisRx does
Polaris Pharmacy Services (Polaris Rx) is an independent, privately held pharmacy services provider founded in 2015 and headquartered at 2900 NW 60th Street, Fort Lauderdale, Florida. It operates 20+ company-operated pharmacies (described as 26 strategically located satellite pharmacy locations) across FL, MI, MN, NC, MD, TN, PA, CA, VA, OH, NJ, MO and IL, and its correctional pharmacy business is licensed in all 50 states. Its customer base is dominated by care settings serving complex, high-risk populations: long-term care and post-acute facilities (skilled nursing, assisted living, hospice, behavioral health, PACE, and drug/alcohol recovery), correctional institutions and justice agencies ranging from small 20-bed facilities to prisons with an average daily population of 5,000, and specialty/infusion patients. Company-reported operating scale includes 1,000+ facilities serviced and 1M+ annual scripts processed, with a firmographic headcount band of 1,001-5,000. A fourth channel, direct-to-consumer, was added through the exclusive U.S. distribution of AstraZeneca's FluMist Home at-home nasal spray flu vaccine, where consumers order via flumist.com for home delivery.
The operating technology is a mix of proprietary software and third-party platforms rather than patent-protected or AI-based systems; no patents are listed and no public API is disclosed. Polaris operates proprietary ordering and claims systems (Pioneer and Framework), integrates with a wide range of eMAR/EHR platforms for real-time data exchange, and provides customer-facing tools including the PolarisConnect web portal (order tracking, drug quoting, invoices, returns, reporting), PolarisPrescribe secure HIPAA-compliant messaging and file sharing with encryption and archiving, PolarisDirect, and the Polaris At Home web-based post-discharge medication program. Physical infrastructure includes advanced cold chain capability at each of five dispensing locations for temperature-controlled biologics, and the CouplerRx-powered supply chain platform providing real-time inventory visibility and licensed FDA repackager capability. No AI/ML capabilities, research, models or data assets are disclosed anywhere in the source material.
Revenue is generated from six streams: per-prescription dispensing and delivery fees to long-term care and post-acute facilities; managed-services correctional contracts covering blister/unit dose/strip packaging, medication returns and reconciliation, MAT billing support and 340B program management; specialty and infusion dispensing reimbursed through payors and patient assistance programs; professional clinical services under PolarisCares (admissions assessment, PDPM clinical assessment, formulary management, pharmacogenomics review); manufacturer distribution and dispensing fees under the exclusive AstraZeneca FluMist Home agreement; and PolarisAcademy continuing education, which is positioned as customer engagement rather than a revenue line. Pricing is quote-based and contracted per facility or per inmate and negotiated with payors — no rate cards, plan tiers or price points are published. Go-to-market is a high-touch direct model in which each facility is supported by a dedicated care team of a customer care representative, nurse consultant and pharmacist, layered with a self-serve PolarisConnect portal, manufacturer and HUB co-marketing (AstraZeneca, Asembia, ASPN Pharmacies), and earned media. The company describes itself as independently and locally owned with no parent, no institutional investors, no disclosed funding rounds, no acquisitions and no disclosed revenue figure, which makes its financial profile materially less transparent than the public long-term care pharmacy comparables.
PolarisRx firmographics
Firmographics- Name
- PolarisRx
- Legal name
- Polaris Pharmacy Services
- Website
- https://polarisrx.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Polaris Rx is an independent, privately held pharmacy services provider delivering clinical and correctional pharmacy programs to long-term care and post-acute facilities, justice agencies and specialty/infusion patients through 20+ company-operated pharmacies, and exclusive U.S. distribution of AstraZeneca's at-home FluMist vaccine.
- Ownership category
- akta.pro rank
PolarisRx industry classification
Industry- Product category
- Pharmacy Services
- NAICS
- All Other Outpatient Care Centers (621498), Offices of All Other Health Practitioners (62139)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro industry
- Prescription Pharmaceutical (Rx) Wholesale DistributionConsumer Products & Retail/Wholesale, Distribution & Category Management/Health, OTC & Pharmacy Wholesale DistributionTraining & Competency Programs for GxP ComplianceHealthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
Keywords
Where PolarisRx is headquartered
LocationHeadquarters
- HQ city
- Fort Lauderdale
- HQ country
- United States
- HQ region
- North America
Offices18 records
Markets served
PolarisRx business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Long-term care and post-acute pharmacy dispensing: Per-prescription dispensing and delivery services to skilled nursing, assisted living, hospice, behavioral, PACE and drug/alcohol recovery facilities, billed to facilities and payors, with recurring facility contracts and a dedicated care team per account enabling upsell of clinical programs.
- Correctional pharmacy services: Contracted pharmacy services to correctional institutions including blister/unit dose/strip packaging, medication returns and reconciliation, MAT program billing support, and 340B program management and reporting; recurring per-inmate/per-facility contracts.
- Specialty and infusion pharmacy: Specialty and infusion pharmacy solutions for complex, high-cost therapies delivered through dedicated specialty pharmacy operations, typically reimbursed through payors and patient assistance programs.
- Clinical and consulting services (PolarisCares): Professional clinical services — admissions assessment, PDPM clinical assessment, formulary management, pharmacogenomics review — sold to facilities to reduce pharmacy costs and optimize reimbursement; also coordinates specialty pharmacy fulfillment.
- Manufacturer distribution and specialty vaccine dispensing: Exclusive U.S. distribution and dispensing of AstraZeneca's FluMist Home at-home flu vaccine service, including cold chain handling, shipping to consumer homes and eligibility processing; a contract-based distribution/fulfilment revenue stream.
- Continuing education (PolarisAcademy): Free continuing education for facility administrators and nurses delivered onsite, via live webinars and through an online learning portal, used as a customer engagement and retention program rather than a direct revenue line.
Go-to-market motion4 records
Distribution channels6 records
Marketing channels9 records
PolarisRx product offering
Product offeringCore offering
Polaris Rx is an independent pharmacy organization that dispenses medications and delivers pharmacy services to care settings with complex, high-risk populations. Its core lines are long-term care and post-acute pharmacy services for skilled nursing, assisted living, hospice, behavioral, PACE and recovery facilities; correctional pharmacy services for jails, detention centers and prisons (unit dose/blister/strip packaging, medication returns, MAT and 340B program support); and specialty and infusion pharmacy for complex, high-cost therapies. It also acts as the exclusive U.S. distributor and dispenser of AstraZeneca's FluMist Home at-home nasal spray flu vaccine service, shipping to consumers' homes with cold chain handling.
Differentiator
Problem solved
Functional benefit
Brands
- PolarisConnect: Customer web portal providing pharmacy alert dashboard, drug quote management, invoice management, returns processing, report subscription, resource access and order tracking.
- PolarisCares
- Polaris At Home
- PolarisDirect
- PolarisPrescribe
- PolarisAcademy
- Polaris Specialty Rx
Products and services
- Long-Term Care and Post-Acute Care Pharmacy Services Around-the-clock pharmacy care for residents of skilled nursing facilities, assisted living, hospice, behavioral health, PACE, and drug/alcohol recovery facilities, including per-prescription dispensing and delivery, emergency and first-dose onsite dispensing, and a dedicated care team (customer care representative, nurse consultant, pharmacist) for each facility account.
- Correctional Pharmacy Services Contracted pharmacy services for jails, detention centers, prisons and state/county justice agencies, including blister, unit dose and strip packaging, medication returns and reconciliation, diabetic supplies and wound care, MAT program billing and tracking, high-cost drug alternatives and therapeutic interchange, 340B program management and reporting, and eMAR integration, with 24/7 support and overnight delivery nationwide.
- Specialty and Infusion Pharmacy (Polaris Specialty Rx) Dedicated specialty pharmacy operation dispensing complex, high-cost specialty and infusion therapies, typically reimbursed through payors and patient assistance programs, and coordinating specialty medication fulfillment with facility clinical services.
- PolarisCares Clinical Services Professional clinical pharmacy services sold to facilities, including admissions assessment, PDPM clinical assessment, formulary management and pharmacogenomics review, intended to reduce facility pharmacy costs and optimize reimbursement while coordinating specialty pharmacy fulfillment.
- PolarisConnect Customer Portal Secure customer web portal for facility clients providing a pharmacy alert dashboard, drug quote management, invoice management, return processing, report subscription, resource access and order tracking.
- PolarisPrescribe Secure Messaging and File Sharing Secure, HIPAA-compliant messaging and file-sharing application enabling verification, real-time alerts, notifications, time-stamping and read receipts, with in-app camera capture of secure images including controlled prescriptions (no image stored on device), cloud synchronization, full encryption and message archiving.
- Polaris At Home Medication Discharge Program Web-based medication discharge program with electronic submissions and follow-up scheduling designed to prevent hospital readmissions and maintain medication compliance after discharge.
- Medicaid Pre-Release Coverage under Waiver 1115 (Justice-Involved Initiative) Program supporting Medicaid pre-release coverage for justice-involved individuals in 19 approved states, including pre-release Medi-Cal enrollment, day-of-release dispensing of prescriptions and DME, MAT support and claims filing for justice-involved populations.
- Exclusive U.S. Distribution and Dispensing of AstraZeneca's FluMist Home At-Home Flu Vaccine Service Contract-based exclusive U.S. distribution, dispensing and home shipment of FluMist Home nasal spray flu vaccine, with eligibility confirmation via flumist.com and cold chain handling at five dispensing locations, renewed for a second consecutive year.
Quantifiable outcome
- Over 125 years of combined correctional pharmacy experience within the team, stated as unmatched by competitors
- +4 more outcomes
Companies that use PolarisRx
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles5 records
PolarisRx technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature8 records
PolarisRx partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered flagship and core.
- AstraZenecaflagshipPolaris Rx was named the exclusive U.S. distributor of AstraZeneca's FluMist Home service for the second consecutive year (announced 2026-09-23), following its selection for the 2025-2026 flu season. Through FluMist Home, consumers order FluMist nasal spray flu vaccine online for delivery directly to their home on a chosen date — the first program of its kind to receive FDA approval. Polaris dispenses and ships from five pharmacy locations with advanced cold chain capability.
- AsembiacoreAsembia is Polaris' HUB services partner for the FluMist Home at-home flu vaccine program launched for the 2025-2026 flu season. Asembia supports the hub model that links the manufacturer, pharmacy distributor and consumer ordering/fulfilment flow for the service.
- ASPN PharmaciescoreASPN Pharmacies provides the technology platform and backend services for the FluMist Home launch, working alongside Polaris as the dispensing and shipping pharmacy distributor and Asembia as HUB services partner. Polaris began dispensing and shipping vaccines from five state-of-the-art pharmacy locations with cold chain capability.
- CouplerRxcorePolaris' correctional pharmacy supply chain is backed by CouplerRx, which provides real-time inventory visibility, fewer disruptions in medication availability, transparent consistent pricing, and licensed FDA repackager services.
Scale indicators13 records
Recent moves7 records
Expansion highlights9 records
PolarisRx competitors and assessment
Company assessmentDirect peers
- PharMerica (BrightSpring Health Services): The largest independent institutional (long-term care and post-acute) pharmacy operator in the U.S., now part of BrightSpring Health Services. It competes directly with Polaris for skilled nursing, assisted living and hospice facility contracts and is the scale benchmark Polaris explicitly differentiates itself from.
- Option Care Health: National home and alternate-site infusion and specialty pharmacy operator serving complex, high-cost therapies under payor reimbursement. It overlaps with Polaris Specialty Rx's infusion and high-cost therapy business and with Polaris's home-delivery orientation.
- Centauri Health Solutions: Specialty pharmacy and home infusion provider focused on complex therapies and payer/provider relationships, including pharmacy benefit services. It is a close analogue to the specialty and infusion segment Polaris is building out alongside its long-term care base.
Emerging players
- CivicaRx: Not-for-profit, non-profit health system-owned specialty pharmacy dispensing limited- and low-cost drugs for underserved patients. It is comparable on dispensing economics and payer-assistance programs in the high-cost specialty space where Polaris Specialty Rx operates.
- Capsule (Capsule Pharmacy): Direct-to-consumer home-delivery online pharmacy with an app-led ordering and fulfillment model. It is the closest consumer-side analogue to Polaris's direct-to-consumer FluMist Home program at flumist.com.
- Alto Pharmacy: Home-delivery pharmacy built around a consumer-facing digital front end and same-day delivery. It is comparable to Polaris's attempt to own a consumer-facing at-home medication/vaccine channel through brand and partner infrastructure.
Broad incumbents
- Cardinal Health: Large healthcare company operating specialty pharmacy, manufacturer services, logistics and at-home solutions. It overlaps Polaris's specialty dispensing and manufacturer-distribution activities but does so as part of a much wider portfolio.
- Cencora (AmerisourceBergen): Global pharmaceutical distributor providing manufacturer services, specialty distribution and logistics — the same functions Polaris performs in scaled form as exclusive U.S. distributor for AstraZeneca's FluMist Home and as an FDA-licensed repackager.
- McKesson: Leading pharmaceutical distributor and specialty pharmacy operator (McKesson Specialty) with manufacturer-facing services. It represents the scaled, vertically integrated alternative to Polaris's independent niche distribution and dispensing model.
Others
- ASPN Pharmacies: Pharmacy technology platform and backend provider for the FluMist Home program and a broader pharmacy services platform for independent pharmacies. It is a named Polaris partner and technology dependency rather than a direct competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
PolarisRx social profiles
Digital presencePolarisRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
PolarisRx leadership team
Management profileNumber of profiles
Profiles10 records
PolarisRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PolarisRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PolarisRx
What does PolarisRx do?
Polaris Rx is an independent pharmacy organization that dispenses medications and delivers pharmacy services to care settings with complex, high-risk populations. Its core lines are long-term care and post-acute pharmacy services for skilled nursing, assisted living, hospice, behavioral, PACE and recovery facilities; correctional pharmacy services for jails, detention centers and prisons (unit dose/blister/strip packaging, medication returns, MAT and 340B program support); and specialty and infusion pharmacy for complex, high-cost therapies. It also acts as the exclusive U.S. distributor and dispenser of AstraZeneca's FluMist Home at-home nasal spray flu vaccine service, shipping to consumers' homes with cold chain handling.
Is PolarisRx a public or private company?
PolarisRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PolarisRx founded?
PolarisRx was founded in 2015. It employs 501 to 1,000 people.
Where is PolarisRx based?
PolarisRx is headquartered in Fort Lauderdale, United States, in the North America region.
How does PolarisRx make money?
Six revenue lines are on record. Long-term care and post-acute pharmacy dispensing is the primary driver. The others are correctional pharmacy services, specialty and infusion pharmacy, clinical and consulting services (PolarisCares), manufacturer distribution and specialty vaccine dispensing and continuing education (PolarisAcademy).
Who are PolarisRx's main competitors?
Direct peers on record are PharMerica (BrightSpring Health Services), Option Care Health and Centauri Health Solutions. Emerging players are CivicaRx, Capsule (Capsule Pharmacy) and Alto Pharmacy. Broad incumbents are Cardinal Health, Cencora (AmerisourceBergen) and McKesson. ASPN Pharmacies is listed as an others.
Does PolarisRx have an API?
No public API is recorded for PolarisRx.
What industry is PolarisRx in?
PolarisRx's product category is Pharmacy Services. Its primary akta.pro industry code is CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution, with a secondary code of HLAGAKAM, Training & Competency Programs for GxP Compliance. Its NAICS code is 621498 and its SIC code is 5912.